key: cord-0957923-avyl04ik authors: Can, Osman; Erkoç, Mustafa; Ozer, Murat; Umeyir Karakanli, Musab; Otunctemur, Alper title: The effect of COVID‐19 on lower urinary tract symptoms in elderly men date: 2021-03-05 journal: Int J Clin Pract DOI: 10.1111/ijcp.14110 sha: 83b8c9c5913d75f7daa4cefa64b7d91c683b7df0 doc_id: 957923 cord_uid: avyl04ik AIMS: The COVID‐19 pandemic is the most important public health problem in 2020. Millions of people have been infected or died because of the outbreak. We know the common symptoms of the disease such as fever and cough. However, all symptoms and features of COVID‐19 are still were not known. We aimed to evaluate the change in lower urinary tract symptoms (LUTS) after COVID‐19 in men. METHODS: We prospectively assessed 94 patients with COVID‐19 during hospitalisation. The patients were divided into two groups according to age, that being over and under age 50. IPSS scores of all patients were enrolled. Additionally, we compared the scores with pre‐COVID‐19 values. RESULTS: LUTS scores were found to be increased in elderly patients. Additionally, the severity of the disease did not correlate with LUTS scores. CONCLUSION: LUTS may be one of the symptoms of COVID‐19 in some patients. Elderly patients with increased LUTS should be evaluated for COVID‐19 when the reason unclear. However, some studies also have reported serious urinary complications. 6 COVID-19 patients, mostly presenting with classical urological symptoms, should not be overlooked nowadays. 7 Urinary frequency is one of the most common symptoms in urological disease. However, Mumm et al reported that urinary frequency is a common symptom in COVID-19 patients. 8 We noticed that hospitalised COVID-19 patients suffered from low urinary tract symptoms (LUTS) . Patients have especially reported increased dysuria symptoms after infection. Therefore, we aimed to evaluate the effect of COVID-19 on LUTS in men in this study. We prospectively evaluated male patients hospitalised for more than 3 weeks because of COVID-19. This study protocol was certified by the Local Ethics Committee and performed in accordance with the Declaration of Helsinki. Written detailed informed consent was obtained from all subjects. Patients whose COVID-19 infections were confirmed with the real-time reverse transcriptase-polymerase chain reaction test were included in the study. Patients who received massive intravenous hydration, drug using affecting urine frequency, benign prostatic hyperplasia or prostate cancer treatment or previously had prostate and urethral surgery were excluded from the study. Additionally, urine analysis was performed for all patients to exclude urinary tract infections. The International Prostate Symptom Score (IPSS) was used to evaluate patients' symptoms. Patients were questioned to rate their previous situation regarding the COVID-19 outbreak. The current scores and pre-COVID-19 scores of the patients were recorded. The patients were divided into two groups, over 50 and under 50 years of age. The current and previous scores were compared within each group separately. One of the most common symptoms in patients with severe COVID-19 is pneumonic infiltration on computed tomography (CT). We categorised the CT images of COVID-19 patients into three score groups. 9 Score 1 means only one side lung was infected minimally. Score 2 means bilateral lung was infected minimal or moderately. Score 3 means massive infection of the bilateral lung. We analysed the correlation between IPSS scores and CT scores of all patients. The data were analysed with the Statistical Package for Social Sciences (SPSS) version 22.0™ (IBM Corporation). The distribution of the variables was measured using the Shapiro-Wilk test. The scores between the two groups were compared with performing the Wilcoxon signed rank test. Spearman's test was used to evaluate correlation. All P values were two-tailed and a P < .05 was considered statistically significant. We assessed a total of 94 participants. The quantity of patients in the under age 50 group was 32 and in over 50 age group 62. IPSS of all patients is presented in Table 1 . The mean age of all patients was 57.5 ± 16.6 years and mean body mass index was 26.2 ± 4.1 kg/m 2 . In the under 50 age group, the IPSS score before COVID-19 was 1.3 ± 1.6 and during COVID-19 it was 1.5 ± 1.6. There was no statistically significant change in the scores (P = .053). In the over 50 age group, the IPSS score before COVID-19 was 5.1 ± 4.1 and during COVID-19 it was 9 ± 6.4. The IPSS score during COVID-19 was statistically significantly higher than the previous score (P < .0001). Scattering chart of CT scores and IPSS scores was presented in 11 Despite these contradictory studies, the urinary frequency was reported as a common symptom of COVID-19 in a recent study. 8 15 The viral invasion may lead to endotheliitis in endothelial cells. 16 Irritative symptoms may occur as a result of bladder mucosal damage. Therefore, one of the reasons for increased IPSS after COVID-19 may be that the urinary bladder is a high-risk group according to ACE2 expression. We consider the other reasons for increased the symptom scores is the age of patients. Many studies indicated that COVID-19 infection causes more severe illness in elderly patients. [17] [18] [19] The reason for this may be related to comorbidities and weak immunity defence of elderly patients. It has been almost 8 months since the pandemic was announced and we may be still at the early phase of the outbreak. The authors have no conflicts of interest to declare. Written consent was obtained. Urology in the time of corona World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 51. World Health Organization World Health Organization. COVID-19 weekly epidemiological update Clinical characteristics of 138 Hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Covid-19 in South Korea -Challenges of subclinical manifestations Caution on kidney dysfunctions of 2019-nCoV patients COVID-19: importance of the awareness of the clinical syndrome by urologists Urinary frequency as a possibly overlooked symptom in covid-19 patients: does SARS-CoV-2 cause viral cystitis? CO-RADS: a categorical CT assessment scheme for patients suspected of having COVID-19-definition and evaluation Stepping forward: urologists' efforts during the COVID-19 outbreak in Singapore Detection of SARS-CoV-2 in Different types of clinical specimens Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients Infection and rapid transmission of SARS-CoV-2 in ferrets Could LUTS be early symptoms of COVID-19 Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Endothelial cell infection and endotheliitis in COVID-19 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical features and short-term outcomes of elderly patients with COVID-19